Common variants of the vitamin D binding protein gene and adverse health outcomes

References

• Haddad JG, Hu YZ, Kowalski MA, et al. Identification of the sterol- and actin-binding domains of plasma vitamin D binding protein (Gc-globulin). Biochemistry 1992;31:7174–81
   PubMed Web of Science ®Google Scholar
• Otterbein LR, Cosio C, Graceffa P, Dominguez R. Crystal structures of the vitamin D-binding protein and its complex with actin: structural basis of the actin-scavenger system. Proc Natl Acad Sci USA 2002;99:8003–8
   PubMed Web of Science ®Google Scholar
• Verboven C, Rabijns A, De MM, et al. A structural basis for the unique binding features of the human vitamin D-binding protein. Nat Struct Biol 2002;9:131–6
   PubMedGoogle Scholar
• Zhang J, Habiel DM, Ramadass M, Kew RR. Identification of two distinct cell binding sequences in the vitamin D binding protein. Biochim Biophys Acta 2010;1803:623–9
   PubMed Web of Science ®Google Scholar
• Bouillon R, Van BH, Rombauts W, De MP. The purification and characterisation of the human-serum binding protein for the 25-hydroxycholecalciferol (transcalciferin). Identity with group-specific component. Eur J Biochem 1976;66:285–91
   PubMedGoogle Scholar
• Daiger SP, Schanfield MS, Cavalli-Sforza LL. Group-specific component (Gc) proteins bind vitamin D and 25-hydroxyvitamin D. Proc Natl Acad Sci USA 1975;72:2076–80
   PubMed Web of Science ®Google Scholar
• Meier U, Gressner O, Lammert F, Gressner AM. Gc-globulin: roles in response to injury. Clin Chem 2006;52:1247–53
   PubMed Web of Science ®Google Scholar
• Bouillon R, Xiang DZ, Convents R, Van BH. Polyunsaturated fatty acids decrease the apparent affinity of vitamin D metabolites for human vitamin D-binding protein. J Steroid Biochem Mol Biol 1992;42:855–61
   PubMed Web of Science ®Google Scholar
• Calvo M, Ena JM. Relations between vitamin D and fatty acid binding properties of vitamin D-binding protein. Biochem Biophys Res Commun 1989;163:14–7
   PubMed Web of Science ®Google Scholar
• Ena JM, Esteban C, Perez MD, et al. Fatty acids bound to vitamin D-binding protein (DBP) from human and bovine sera. Biochem Int 1989;19:1–7
   PubMedGoogle Scholar
• Van BH, Bouillon R, De MP. Vitamin D-binding protein (Gc-globulin) binds actin. J Biol Chem 1980;255:2270–2
   PubMed Web of Science ®Google Scholar
• Williams MH, Van Alstyne EL, Galbraith RM. Evidence of a novel association of unsaturated fatty acids with Gc (vitamin D-binding protein). Biochem Biophys Res Commun 1988;153:1019–24
   PubMed Web of Science ®Google Scholar
• Cho EH, Kim MR, Kim HJ, et al. The discovery of biomarkers for type 2 diabetic nephropathy by serum proteome analysis. Proteomics Clin Appl 2007;1:352–61
   PubMed Web of Science ®Google Scholar
• Pawlik TM, Hawke DH, Liu Y, et al. Proteomic analysis of nipple aspirate fluid from women with early-stage breast cancer using isotope-coded affinity tags and tandem mass spectrometry reveals differential expression of vitamin D binding protein. BMC Cancer 2006;6:68
   PubMed Web of Science ®Google Scholar
• Bijian K, Mlynarek AM, Balys RL, et al. Serum proteomic approach for the identification of serum biomarkers contributed by oral squamous cell carcinoma and host tissue microenvironment. J Proteome Res 2009;8:2173–85
   PubMed Web of Science ®Google Scholar
• Wu Y, Shu R, Luo LJ, et al. Initial comparison of proteomic profiles of whole unstimulated saliva obtained from generalized aggressive periodontitis patients and healthy control subjects. J Periodontal Res 2009;44:636–44
   PubMed Web of Science ®Google Scholar
• Xiao F, Chen D, Lu Y, et al. Proteomic analysis of cerebrospinal fluid from patients with idiopathic temporal lobe epilepsy. Brain Res 2009;255:180–9
   Google Scholar
• Zhang J, Sokal I, Peskind ER, et al. CSF multianalyte profile distinguishes Alzheimer and Parkinson diseases. Am J Clin Pathol 2008;129:526–9
   PubMed Web of Science ®Google Scholar
• Duan X, Lu Q, Xue P, et al. Proteomic analysis of aqueous humor from patients with myopia. Mol Vis 2008;14:370–7
   PubMed Web of Science ®Google Scholar
• Hattori N, Oda S, Sadahiro T, et al. YKL-40 identified by proteomic analysis as a biomarker of sepsis. Shock 2009;32:393–400
   PubMed Web of Science ®Google Scholar
• Bai S, Liu S, Guo X, et al. Proteome analysis of biomarkers in the cerebrospinal fluid of neuromyelitis optica patients. Mol Vis 2009;15:1638–48
   PubMed Web of Science ®Google Scholar
• Greco M, Mitri MD, Chiriaco F, et al. Serum proteomic profile of cutaneous malignant melanoma and relation to cancer progression: association to tumor derived alpha-N-acetylgalactosaminidase activity. Cancer Lett 2009;283:222–9
   PubMed Web of Science ®Google Scholar
• Chan KY, Lai PB, Squire JA, et al. Positional expression profiling indicates candidate genes in deletion hotspots of hepatocellular carcinoma. Mod Pathol 2006;19:1546–54
   PubMed Web of Science ®Google Scholar
• Gressner OA, Gao C, Siluschek M, et al. Inverse association between serum concentrations of actin-free vitamin D-binding protein and the histopathological extent of fibrogenic liver disease or hepatocellular carcinoma. Eur J Gastroenterol Hepatol 2009;21:990–5
   PubMed Web of Science ®Google Scholar
• Kim BK, Lee JW, Park PJ, et al. The multiplex bead array approach to identifying serum biomarkers associated with breast cancer. Breast Cancer Res 2009;11:R22
   PubMed Web of Science ®Google Scholar
• Anagnostopoulos AK, Kolialexi A, Mavrou A, et al. Proteomic analysis of amniotic fluid in pregnancies with Klinefelter syndrome foetuses. J Proteomics 2010;73:943–50
   PubMed Web of Science ®Google Scholar
• Blanton D, Han Z, Bierschenk L, et al. Reduced serum vitamin d-binding protein levels are associated with type 1 diabetes. Diabetes 2011;60:2566–70
   PubMed Web of Science ®Google Scholar
• Song YH, Naumova AK, Liebhaber SA, Cooke NE. Physical and meiotic mapping of the region of human chromosome 4q11-q13 encompassing the vitamin D binding protein DBP/Gc-globulin and albumin multigene cluster. Genome Res 1999;9:581–7
   PubMed Web of Science ®Google Scholar
• Hiroki T, Song YH, Liebhaber SA, Cooke NE. The human vitamin D-binding protein gene contains locus control determinants sufficient for autonomous activation in hepatic chromatin. Nucleic Acids Res 2006;34:2154–65
   PubMed Web of Science ®Google Scholar
• Daiger SP, Miller M, Chakraborty R. Heritability of quantitative variation at the group-specific component (Gc) locus. Am J Hum Genet 1984;36:663–76
   PubMed Web of Science ®Google Scholar
• Hunter D, De LM, Snieder H, et al. Genetic contribution to bone metabolism, calcium excretion, and vitamin D and parathyroid hormone regulation. J Bone Miner Res 2001;16:371–8
   PubMed Web of Science ®Google Scholar
• Constans J, Viau M. Group-specific component: evidence for two subtypes of the Gc1 gene. Science 1977;198:1070–1
   PubMed Web of Science ®Google Scholar
• Van BH, Bouillon R, De MP. The heterogeneity of human Gc-globulin. J Biol Chem 1978;253:6344–5
   PubMed Web of Science ®Google Scholar
• Lauridsen AL, Vestergaard P, Nexo E. Mean serum concentration of vitamin D-binding protein (Gc globulin) is related to the Gc phenotype in women. Clin Chem 2001;47:753–6
   Google Scholar
• Constans J, Arlet P, Viau M, Bouissou C. Unusual sialilation of the serum DBP associated with the Gc 1 allele in alcoholic cirrhosis of the liver. Clin Chim Acta 1983;130:219–30
   PubMed Web of Science ®Google Scholar
• Fu L, Cade C, Holm SS, et al. Relationship of functional T436K polymorphism in vitamin D binding protein (DBP) with serum 25-hydroxyvitamin D [25(OH)D], DBP concentration and binding capacity: a pilot study. Clin Chem 2010;56:A154
   PubMed Web of Science ®Google Scholar
• Ahn J, Yu K, Stolzenberg-Solomon R, et al. Genome-wide association study of circulating vitamin D levels. Hum Mol Genet 2010;19:2739–45
   PubMed Web of Science ®Google Scholar
• Wang TJ, Zhang F, Richards JB, et al. Common genetic determinants of vitamin D insufficiency: a genome-wide association study. Lancet 2010;376:180–8
   PubMed Web of Science ®Google Scholar
• Borges CR, Jarvis JW, Oran PE, Nelson RW. Population studies of Vitamin D binding protein microheterogeneity by mass spectrometry lead to characterization of its genotype-dependent O-glycosylation patterns. J Proteome Res 2008;7:4143–53
   PubMed Web of Science ®Google Scholar
• Borges CR, Jarvis JW, Oran PE, et al. Population studies of intact vitamin D binding protein by affinity capture ESI-TOF-MS. J Biomol Tech 2008;19:167–76
   PubMedGoogle Scholar
• Lauridsen AL, Vestergaard P, Hermann AP, et al. Plasma concentrations of 25-hydroxy-vitamin D and 1,25-dihydroxy-vitamin D are related to the phenotype of Gc (vitamin D-binding protein): a cross-sectional study on 595 early postmenopausal women. Calcif Tissue Int 2005;77:15–22
   PubMed Web of Science ®Google Scholar
• Lu L, Sheng H, Li H, et al. Associations between common variants in GC and DHCR7/NADSYN1 and vitamin D concentration in Chinese Hans. Hum Genet 2012;131:505–12
   PubMed Web of Science ®Google Scholar
• Sinotte M, Diorio C, Berube S, et al. Genetic polymorphisms of the vitamin D binding protein and plasma concentrations of 25-hydroxyvitamin D in premenopausal women. Am J Clin Nutr 2009;89:634–40
   PubMed Web of Science ®Google Scholar
• Fu L, Yun F, Oczak M, et al. Common genetic variants of the vitamin D binding protein (DBP) predict differences in response of serum 25-hydroxyvitamin D [25(OH)D] to vitamin D supplementation. Clin Biochem 2009;42:1174–7
   PubMed Web of Science ®Google Scholar
• National Cancer Institute. SNP500 cancer database. National Cancer Institute; 2010. Available from: http://variantgps.nci.nih.gov/cgfseq/pages/snp500.do [last accessed 22 Jan 2013]
   Google Scholar
• Gozdzik A, Zhu J, Wong BY, et al. Association of vitamin D binding protein (VDBP) polymorphisms and serum 25(OH)D concentrations in a sample of young Canadian adults of different ancestry. J Steroid Biochem Mol Biol 2011;127:405–12
   PubMed Web of Science ®Google Scholar
• Bouillon R, Okamura WH, Norman AW. Structure-function relationships in the vitamin D endocrine system. Endocr Rev 1995;16:200–57
   PubMed Web of Science ®Google Scholar
• Holick MF, Binkley NC, Bischoff-Ferrari HA, et al. Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab 2011;96:1911–30
   PubMed Web of Science ®Google Scholar
• Feldman D, Pike JW, Adams JS. Vitamin D. 3rd ed. Amsterdam: Academic Press; 2011
   Google Scholar
• Bikle D. “Vitamin D system in mineral homeostasis”. In: Singer F, ed. Disease of bone and mineral metabolism. Endotext.com, 2009 . Available from: http://www.endotext.org/parathyroid/index.htm
   Google Scholar
• Hewison M. An update on vitamin D and human immunity. Clin Endocrinol (Oxf) 2012;76:315–25
   PubMed Web of Science ®Google Scholar
• Martineau AR, Wilkinson KA, Newton SM, et al. IFN-gamma- and TNF-independent vitamin D-inducible human suppression of mycobacteria: the role of cathelicidin LL-37. J Immunol 2007;178:7190–8
   PubMed Web of Science ®Google Scholar
• Deeb KK, Trump DL, Johnson CS. Vitamin D signalling pathways in cancer: potential for anticancer therapeutics. Nat Rev Cancer 2007;7:684–700
   PubMed Web of Science ®Google Scholar
• Liu PT, Stenger S, Li H, et al. Toll-like receptor triggering of a vitamin D-mediated human antimicrobial response. Science 2006;311:1770–3
   PubMed Web of Science ®Google Scholar
• Liu PT, Schenk M, Walker VP, et al. Convergence of IL-1beta and VDR activation pathways in human TLR2/1-induced antimicrobial responses. PLoS One 2009;4:e5810
   PubMed Web of Science ®Google Scholar
• Binder R, Kress A, Kan G, et al. Neutrophil priming by cytokines and vitamin D binding protein (Gc-globulin): impact on C5a-mediated chemotaxis, degranulation and respiratory burst. Mol Immunol 1999;36:885–92
   PubMed Web of Science ®Google Scholar
• Kew RR, Webster RO. Gc-globulin (vitamin D-binding protein) enhances the neutrophil chemotactic activity of C5a and C5a des Arg. J Clin Invest 1988;82:364–9
   PubMed Web of Science ®Google Scholar
• Kew RR, Fisher JA, Webster RO. Co-chemotactic effect of Gc-globulin (vitamin D binding protein) for C5a. Transient conversion into an active co-chemotaxin by neutrophils. J Immunol 1995;155:5369–74
   PubMed Web of Science ®Google Scholar
• Piquette CA, Robinson-Hill R, Webster RO. Human monocyte chemotaxis to complement-derived chemotaxins is enhanced by Gc-globulin. J Leukoc Biol 1994;55:349–54
   PubMed Web of Science ®Google Scholar
• Shah AB, DiMartino SJ, Trujillo G, Kew RR. Selective inhibition of the C5a chemotactic cofactor function of the vitamin D binding protein by 1,25(OH)2 vitamin D3. Mol Immunol 2006;43:1109–15
   PubMed Web of Science ®Google Scholar
• Yamamoto N, Homma S, Millman I. Identification of the serum factor required for in vitro activation of macrophages. Role of vitamin D3-binding protein (group specific component, Gc) in lysophospholipid activation of mouse peritoneal macrophages. J Immunol 1991;147:273–80
   PubMed Web of Science ®Google Scholar
• Yamamoto N, Kumashiro R, Yamamoto M, et al. Regulation of inflammation-primed activation of macrophages by two serum factors, vitamin D3-binding protein and albumin. Infect Immun 1993;61:5388–91
   PubMed Web of Science ®Google Scholar
• Dahl B, Schiodt FV, Ott P, et al. Plasma concentration of Gc-globulin is associated with organ dysfunction and sepsis after injury. Crit Care Med 2003;31:152–6
   PubMed Web of Science ®Google Scholar
• Haddad JG, Harper KD, Guoth M, et al. Angiopathic consequences of saturating the plasma scavenger system for actin. Proc Natl Acad Sci USA 1990;87:1381–5
   PubMed Web of Science ®Google Scholar
• Badawi A, Klip A, Haddad P, et al. Type 2 diabetes mellitus and inflammation: Prospects for biomarkers of risk and nutritional intervention. Diabetes Metab Syndr Obes 2010;3:173–86
   PubMedGoogle Scholar
• Pani MA, Donner H, Herwig J, et al. Vitamin D binding protein alleles and susceptibility for type 1 diabetes in Germans. Autoimmunity 1999;31:67–72
   PubMed Web of Science ®Google Scholar
• Danescu LG, Levy S, Levy J. Vitamin D and diabetes mellitus. Endocrine 2009;35:11–7
   PubMed Web of Science ®Google Scholar
• Hirai M, Suzuki S, Hinokio Y, et al. Variations in vitamin D-binding protein (group-specific component protein) are associated with fasting plasma insulin levels in Japanese with normal glucose tolerance. J Clin Endocrinol Metab 2000;85:1951–53
   PubMed Web of Science ®Google Scholar
• Szathmary EJ. The effect of Gc genotype on fasting insulin level in Dogrib Indians. Hum Genet 1987;75:368–72
   PubMed Web of Science ®Google Scholar
• Baier LJ, Dobberfuhl AM, Pratley RE, et al. Variations in the vitamin D-binding protein (Gc locus) are associated with oral glucose tolerance in nondiabetic Pima Indians. J Clin Endocrinol Metab 1998;83:2993–96
   PubMed Web of Science ®Google Scholar
• Iyengar S, Hamman RF, Marshall JA, et al. On the role of vitamin D binding globulin in glucose homeostasis: results from the San Luis Valley Diabetes Study. Genet Epidemiol 1989;6:691–8
   PubMed Web of Science ®Google Scholar
• Hirai M, Suzuki S, Hinokio Y, et al. Group specific component protein genotype is associated with NIDDM in Japan. Diabetologia 1998;41:742–3
   PubMed Web of Science ®Google Scholar
• Braun A, Bichlmaier R, Muller B, Cleve H. Molecular evaluation of an Alu repeat including a polymorphic variable poly(dA) (AluVpA) in the vitamin D binding protein (DBP) gene. Hum Genet 1993;90:526–32
   PubMed Web of Science ®Google Scholar
• Klupa T, Malecki M, Hanna L, et al. Amino acid variants of the vitamin D-binding protein and risk of diabetes in white Americans of European origin. Eur J Endocrinol 1999;141:490–93
   PubMed Web of Science ®Google Scholar
• Ye WZ, Dubois-Laforgue D, Bellanne-Chantelot C, et al. Variations in the vitamin D-binding protein (Gc locus) and risk of type 2 diabetes mellitus in French Caucasians. Metabolism 2001;50:366–69
   PubMed Web of Science ®Google Scholar
• Malecki MT, Klupa T, Wanic K, et al. Vitamin D binding protein gene and genetic susceptibility to type 2 diabetes mellitus in a Polish population. Diabetes Res Clin Pract 2002;57:99–104
   PubMed Web of Science ®Google Scholar
• Lauridsen AL, Vestergaard P, Hermann AP, et al. Female premenopausal fracture risk is associated with gc phenotype. J Bone Miner Res 2004;19:875–81
   PubMed Web of Science ®Google Scholar
• Bischoff-Ferrari HA, Dietrich T, Orav EJ, Dawson-Hughes B. Positive association between 25-hydroxy vitamin D levels and bone mineral density: a population-based study of younger and older adults. Am J Med 2004;116:634–9
   PubMed Web of Science ®Google Scholar
• Kuchuk NO, van Schoor NM, Pluijm SM, et al. Vitamin D status, parathyroid function, bone turnover, and BMD in postmenopausal women with osteoporosis: global perspective. J Bone Miner Res 2009;24:693–701
   PubMed Web of Science ®Google Scholar
• Tang BM, Eslick GD, Nowson C, et al. Use of calcium or calcium in combination with vitamin D supplementation to prevent fractures and bone loss in people aged 50 years and older: a meta-analysis. Lancet 2007;370:657–66
   PubMed Web of Science ®Google Scholar
• Yamamoto N, Homma S. Vitamin D3 binding protein (group-specific component) is a precursor for the macrophage-activating signal factor from lysophosphatidylcholine-treated lymphocytes. Proc Natl Acad Sci USA 1991;88:8539–43
   PubMed Web of Science ®Google Scholar
• Swamy N, Ghosh S, Schneider GB, Ray R. Baculovirus-expressed vitamin D-binding protein-macrophage activating factor (DBP-maf) activates osteoclasts and binding of 25-hydroxyvitamin D(3) does not influence this activity. J Cell Biochem 2001;81:535–46
   PubMed Web of Science ®Google Scholar
• Yamamoto N, Naraparaju VR, Orchard PJ. Defective lymphocyte glycosidases in the macrophage activation cascade of juvenile osteopetrosis. Blood 1996;88:1473–8
   PubMed Web of Science ®Google Scholar
• Schneider GB, Benis KA, Flay NW, et al. Effects of vitamin D binding protein-macrophage activating factor (DBP-MAF) infusion on bone resorption in two osteopetrotic mutations. Bone 1995;16:657–62
   PubMed Web of Science ®Google Scholar
• Ezura Y, Nakajima T, Kajita M, et al. Association of molecular variants, haplotypes, and linkage disequilibrium within the human vitamin D-binding protein (DBP) gene with postmenopausal bone mineral density. J Bone Miner Res 2003;18:1642–49
   PubMed Web of Science ®Google Scholar
• Papiha SS, Allcroft LC, Kanan RM, et al. Vitamin D binding protein gene in male osteoporosis: association of plasma DBP and bone mineral density with (TAAA)(n)-Alu polymorphism in DBP. Calcif Tissue Int 1999;65:262–6
   PubMed Web of Science ®Google Scholar
• Al oanzi ZH, Tuck SP, Mastana SS, et al. Vitamin D-binding protein gene microsatellite polymorphism influences BMD and risk of fractures in men. Osteoporos Int 2008;19:951–60
   PubMed Web of Science ®Google Scholar
• Fang Y, van Meurs JB, Arp P, et al. Vitamin D binding protein genotype and osteoporosis. Calcif Tissue Int 2009;85:85–93
   PubMed Web of Science ®Google Scholar
• Schellenberg D, Pare PD, Weir TD, et al. Vitamin D binding protein variants and the risk of COPD. Am J Respir Crit Care Med 1998;157:957–61
   PubMed Web of Science ®Google Scholar
• Horne SL, Cockcroft DW, Dosman JA. Possible protective effect against chronic obstructive airways disease by the GC2 allele. Hum Hered 1990;40:173–6
   PubMed Web of Science ®Google Scholar
• Kueppers F, Miller RD, Gordon H, et al. Familial prevalence of chronic obstructive pulmonary disease in a matched pair study. Am J Med 1977;63:336–42
   PubMed Web of Science ®Google Scholar
• Wood AM, Bassford C, Webster D, et al. Vitamin D-binding protein contributes to COPD by activation of alveolar macrophages. Thorax 2011;66:205–10
   PubMed Web of Science ®Google Scholar
• Ito I, Nagai S, Hoshino Y, et al. Risk and severity of COPD is associated with the group-specific component of serum globulin 1F allele. Chest 2004;125:63–70
   PubMed Web of Science ®Google Scholar
• Ishii T, Keicho N, Teramoto S, et al. Association of Gc-globulin variation with susceptibility to COPD and diffuse panbronchiolitis. Eur Respir J 2001;18:753–7
   PubMed Web of Science ®Google Scholar
• Shen LH, Zhang XM, Su DJ, et al. Association of vitamin D binding protein variants with susceptibility to chronic obstructive pulmonary disease. J Int Med Res 2010;38:1093–8
   PubMed Web of Science ®Google Scholar
• Nagasawa H, Uto Y, Sasaki H, et al. Gc protein (vitamin D-binding protein): Gc genotyping and GcMAF precursor activity. Anticancer Res 2005;25:3689–95
   PubMed Web of Science ®Google Scholar
• Janssens W, Bouillon R, Claes B, et al. Vitamin D deficiency is highly prevalent in COPD and correlates with variants in the vitamin D-binding gene. Thorax 2010;65:215–20
   PubMed Web of Science ®Google Scholar
• Kasuga I, Pare PD, Ruan J, et al. Lack of association of group specific component haplotypes with lung function in smokers. Thorax 2003;58:790–3
   PubMed Web of Science ®Google Scholar
• Sandford AJ, Chagani T, Weir TD, et al. Susceptibility genes for rapid decline of lung function in the lung health study. Am J Respir Crit Care Med 2001;163:469–73
   PubMed Web of Science ®Google Scholar
• Holt PG, Macaubas C, Stumbles PA, Sly PD. The role of allergy in the development of asthma. Nature 1999;402:B12–17
   PubMed Web of Science ®Google Scholar
• Litonjua AA, Weiss ST. Is vitamin D deficiency to blame for the asthma epidemic? J Allergy Clin Immunol 2007;120:1031–5
   PubMed Web of Science ®Google Scholar
• Masoli M, Fabian D, Holt S, Beasley R. The global burden of asthma: executive summary of the GINA Dissemination Committee report. Allergy 2004;59:469–78
   PubMed Web of Science ®Google Scholar
• Hollams EM, Hart PH, Holt BJ, et al. Vitamin D and atopy and asthma phenotypes in children: a longitudinal cohort study. Eur Respir J 2011;38:1320–7
   PubMed Web of Science ®Google Scholar
• Pinto JM, Schneider J, Perez R, et al. Serum 25-hydroxyvitamin D levels are lower in urban African American subjects with chronic rhinosinusitis. J Allergy Clin Immunol 2008;122:415–7
   PubMed Web of Science ®Google Scholar
• Freishtat RJ, Iqbal SF, Pillai DK, et al. High prevalence of vitamin D deficiency among inner-city African American youth with asthma in Washington, DC. J Pediatr 2010;156:948–52
   PubMed Web of Science ®Google Scholar
• Hypponen E, Sovio U, Wjst M, et al. Infant vitamin d supplementation and allergic conditions in adulthood: northern Finland birth cohort 1966. Ann NY Acad Sci 2004;1037:84–95
   PubMed Web of Science ®Google Scholar
• Wjst M, Hypponen E. Vitamin D serum levels and allergic rhinitis. Allergy 2007;62:1085–6
   PubMed Web of Science ®Google Scholar
• Camargo CA, Jr, Ingham T, Wickens K, et al. Cord-blood 25-hydroxyvitamin D levels and risk of respiratory infection, wheezing, and asthma. Pediatrics 2011;127:e180–7
   PubMed Web of Science ®Google Scholar
• Pillai DK, Iqbal SF, Benton AS, et al. Associations between genetic variants in vitamin D metabolism and asthma characteristics in Young African Americans: a pilot study. J Investig Med 2011;59:938–46
   PubMed Web of Science ®Google Scholar
• Bosse Y, Lemire M, Poon AH, et al. Asthma and genes encoding components of the vitamin D pathway. Respir Res 2009;10:98
   PubMed Web of Science ®Google Scholar
• Krstic G. Asthma prevalence associated with geographical latitude and regional insolation in the United States of America and Australia. PLoS One 2011;6:e18492
   PubMed Web of Science ®Google Scholar
• Hughes AM, Lucas RM, Ponsonby AL, et al. The role of latitude, ultraviolet radiation exposure and vitamin D in childhood asthma and hayfever: an Australian multicenter study. Pediatr Allergy Immunol 2011;22:327–33
   PubMed Web of Science ®Google Scholar
• Annesi-Maesano I. Perinatal events, vitamin D, and the development of allergy. Pediatr Res 2002;52:3–5
   PubMed Web of Science ®Google Scholar
• Gorman S, Judge MA, Burchell JT, et al. 1,25-Dihydroxyvitamin D3 enhances the ability of transferred CD4+ CD25+ cells to modulate T helper type 2-driven asthmatic responses. Immunology 2010;130:181–92
   PubMed Web of Science ®Google Scholar
• Pichler J, Gerstmayr M, Szepfalusi Z, et al. 1 alpha,25(OH)2D3 inhibits not only Th1 but also Th2 differentiation in human cord blood T cells. Pediatr Res 2002;52:12–8
   PubMed Web of Science ®Google Scholar
• Li F, Jiang L, Willis-Owen SA, et al. Vitamin D binding protein variants associate with asthma susceptibility in the Chinese Han population. BMC Med Genet 2011;12:103
   PubMed Web of Science ®Google Scholar
• Wjst M, Altmuller J, Faus-Kessler T, et al. Asthma families show transmission disequilibrium of gene variants in the vitamin D metabolism and signalling pathway. Respir Res 2006;7:60
   PubMed Web of Science ®Google Scholar
• Pola R. Inflammatory markers for ischaemic stroke. Thromb Haemost 2009;101:800–1
   PubMed Web of Science ®Google Scholar
• Wang X, Cheng S, Brophy VH, et al. A meta-analysis of candidate gene polymorphisms and ischemic stroke in 6 study populations: association of lymphotoxin-alpha in nonhypertensive patients. Stroke 2009;40:683–95
   PubMed Web of Science ®Google Scholar
• Pilz S, Dobnig H, Fischer JE, et al. Low vitamin d levels predict stroke in patients referred to coronary angiography. Stroke 2008;39:2611–3
   PubMed Web of Science ®Google Scholar
• Lobo R. Endometriosis: etiology, pathology, diagnosis, management. In: Katz Vea, ed. Comprehensive gynecology. 5th ed. Philadelphia: Mosby Elsevier; 2011:473–500
   Google Scholar
• Wellbery C. Diagnosis and treatment of endometriosis. Am Fam Physician 1999;60:1753–8
   PubMed Web of Science ®Google Scholar
• Akoum A, Kong J, Metz C, Beaumont MC. Spontaneous and stimulated secretion of monocyte chemotactic protein-1 and macrophage migration inhibitory factor by peritoneal macrophages in women with and without endometriosis. Fertil Steril 2002;77:989–94
   PubMed Web of Science ®Google Scholar
• Faserl K, Golderer G, Kremser L, et al. Polymorphism in vitamin D-binding protein as a genetic risk factor in the pathogenesis of endometriosis. J Clin Endocrinol Metab 2011;96:E233–41
   PubMed Web of Science ®Google Scholar
• Eloranta JJ, Wenger C, Mwinyi J, et al. Association of a common vitamin D-binding protein polymorphism with inflammatory bowel disease. Pharmacogenet Genomics 2011;21:559–64
   PubMed Web of Science ®Google Scholar
• Mohr SB, Garland CF, Gorham ED, et al. Is ultraviolet B irradiance inversely associated with incidence rates of endometrial cancer: an ecological study of 107 countries. Prev Med 2007;45:327–31
   PubMed Web of Science ®Google Scholar
• Mohr SB, Garland CF, Gorham ED, et al. Could ultraviolet B irradiance and vitamin D be associated with lower incidence rates of lung cancer? J Epidemiol Community Health 2008;62:69–74
   PubMed Web of Science ®Google Scholar
• Porojnicu AC, Robsahm TE, Dahlback A, et al. Seasonal and geographical variations in lung cancer prognosis in Norway. Does vitamin D from the sun play a role? Lung Cancer 2007;55:263–70
   PubMed Web of Science ®Google Scholar
• Gorham ED, Garland FC, Garland CF. Sunlight and breast cancer incidence in the USSR. Int J Epidemiol 1990;19:820–4
   PubMed Web of Science ®Google Scholar
• John EM, Schwartz GG, Dreon DM, Koo J. Vitamin D and breast cancer risk: the NHANES I Epidemiologic follow-up study, 1971–1975 to 1992. National Health and Nutrition Examination Survey. Cancer Epidemiol Biomarkers Prev 1999;8:399–406
   PubMed Web of Science ®Google Scholar
• Lowe LC, Guy M, Mansi JL, et al. Plasma 25-hydroxy vitamin D concentrations, vitamin D receptor genotype and breast cancer risk in a UK Caucasian population. Eur J Cancer 2005;41:1164–9
   PubMed Web of Science ®Google Scholar
• Reinhold U, Schmitz B, Kurbacher C, et al. Circulating 25-hydroxyvitamin D concentration in German cancer patients. Oncol Rep 2008;20:1539–43
   PubMed Web of Science ®Google Scholar
• Agborsangaya CB, Surcel HM, Toriola AT, et al. Serum 25-hydroxyvitamin D at pregnancy and risk of breast cancer in a prospective study. Eur J Cancer 2010;46:467–70
   PubMed Web of Science ®Google Scholar
• Hanchette CL, Schwartz GG. Geographic patterns of prostate cancer mortality. Evidence for a protective effect of ultraviolet radiation. Cancer 1992;70:2861–9
   PubMed Web of Science ®Google Scholar
• Colli JL, Colli A. International comparisons of prostate cancer mortality rates with dietary practices and sunlight levels. Urol Oncol 2006;24:184–94
   PubMed Web of Science ®Google Scholar
• Li H, Stampfer MJ, Hollis JB, et al. A prospective study of plasma vitamin D metabolites, vitamin D receptor polymorphisms, and prostate cancer. PLoS Med 2007;4:e103
   PubMed Web of Science ®Google Scholar
• Colli JL, Grant WB. Solar ultraviolet B radiation compared with prostate cancer incidence and mortality rates in United States. Urology 2008;71:531–5
   PubMed Web of Science ®Google Scholar
• Lefkowitz ES, Garland CF. Sunlight, vitamin D, and ovarian cancer mortality rates in US women. Int J Epidemiol 1994;23:1133–6
   PubMed Web of Science ®Google Scholar
• Garland CF, Mohr SB, Gorham ED, et al. Role of ultraviolet B irradiance and vitamin D in prevention of ovarian cancer. Am J Prev Med 2006;31:512–4
   PubMed Web of Science ®Google Scholar
• Braun MM, Helzlsouer KJ, Hollis BW, Comstock GW. Colon cancer and serum vitamin D metabolite levels 10–17 years prior to diagnosis. Am J Epidemiol 1995;142:608–11
   PubMed Web of Science ®Google Scholar
• Feskanich D, Ma J, Fuchs CS, et al. Plasma vitamin D metabolites and risk of colorectal cancer in women. Cancer Epidemiol Biomarkers Prev 2004;13:1502–8
   PubMed Web of Science ®Google Scholar
• Freedman DM, Looker AC, Chang SC, Graubard BI. Prospective study of serum vitamin D and cancer mortality in the United States. J Natl Cancer Inst 2007;99:1594–602
   PubMed Web of Science ®Google Scholar
• Garland CF, Comstock GW, Garland FC, et al. Serum 25-hydroxyvitamin D and colon cancer: eight-year prospective study. Lancet 1989;2:1176–8
   PubMed Web of Science ®Google Scholar
• Gorham ED, Garland CF, Garland FC, et al. Optimal vitamin D status for colorectal cancer prevention: a quantitative meta analysis. Am J Prev Med 2007;32:210–6
   PubMed Web of Science ®Google Scholar
• Wactawski-Wende J, Kotchen JM, Anderson GL, et al. Calcium plus vitamin D supplementation and the risk of colorectal cancer. N Engl J Med 2006;354:684–96
   PubMed Web of Science ®Google Scholar
• Otani T, Iwasaki M, Sasazuki S, et al. Plasma vitamin D and risk of colorectal cancer: the Japan Public Health Center-Based Prospective Study. Br J Cancer 2007;97:446–51
   PubMed Web of Science ®Google Scholar
• Wu K, Feskanich D, Fuchs CS, et al. A nested case control study of plasma 25-hydroxyvitamin D concentrations and risk of colorectal cancer. J Natl Cancer Inst 2007;99:1120–9
   PubMed Web of Science ®Google Scholar
• Yin L, Grandi N, Raum E, et al. Meta-analysis: longitudinal studies of serum vitamin D and colorectal cancer risk. Aliment Pharmacol Ther 2009;30:113–25
   PubMed Web of Science ®Google Scholar
• Tangrea J, Helzlsouer K, Pietinen P, et al. Serum levels of vitamin D metabolites and the subsequent risk of colon and rectal cancer in Finnish men. Cancer Causes Control 1997;8:615–25
   PubMed Web of Science ®Google Scholar
• Gandini S, Boniol M, Haukka J, et al. Meta-analysis of observational studies of serum 25-hydroxyvitamin D levels and colorectal, breast and prostate cancer and colorectal adenoma. Int J Cancer 2011;128:1414–24
   PubMed Web of Science ®Google Scholar
• Yin L, Grandi N, Raum E, et al. Meta-analysis: serum vitamin D and breast cancer risk. Eur J Cancer 2010;46:2196–205
   PubMed Web of Science ®Google Scholar
• Kisker O, Onizuka S, Becker CM, et al. Vitamin D binding protein-macrophage activating factor (DBP-maf) inhibits angiogenesis and tumor growth in mice. Neoplasia 2003;5:32–40
   PubMed Web of Science ®Google Scholar
• Yamamoto N, Suyama H, Yamamoto N, Ushijima N. Immunotherapy of metastatic breast cancer patients with vitamin D-binding protein-derived macrophage activating factor (GcMAF). Int J Cancer 2008;122:461–7
   PubMed Web of Science ®Google Scholar
• Pacini S, Punzi T, Morucci G, et al. Effects of vitamin D-binding protein-derived macrophage-activating factor on human breast cancer cells. Anticancer Res 2012;32:45–52
   PubMed Web of Science ®Google Scholar
• Welsh J, Wietzke JA, Zinser GM, et al. Vitamin D-3 receptor as a target for breast cancer prevention. J Nutr 2003;133:2425S–33S
   PubMed Web of Science ®Google Scholar
• Welsh J. Vitamin D and breast cancer: insights from animal models. Am J Clin Nutr 2004;80:1721S–4S
   PubMed Web of Science ®Google Scholar
• Lowe L, Hansen CM, Senaratne S, Colston KW. Mechanisms implicated in the growth regulatory effects of vitamin D compounds in breast cancer cells. Recent Results Cancer Res 2003;164:99–110
   PubMedGoogle Scholar
• Colston KW, Hansen CM. Mechanisms implicated in the growth regulatory effects of vitamin D in breast cancer. Endocr Relat Cancer 2002;9:45–59
   PubMed Web of Science ®Google Scholar
• McCullough ML, Stevens VL, Diver WR, et al. Vitamin D pathway gene polymorphisms, diet, and risk of postmenopausal breast cancer: a nested case-control study. Breast Cancer Res 2007;9:R9
   PubMed Web of Science ®Google Scholar
• Abbas S, Linseisen J, Slanger T, et al. The Gc2 allele of the vitamin D binding protein is associated with a decreased postmenopausal breast cancer risk, independent of the vitamin D status. Cancer Epidemiol Biomarkers Prev 2008;17:1339–43
   PubMed Web of Science ®Google Scholar
• Anderson LN, Cotterchio M, Cole DE, Knight JA. Vitamin D-related genetic variants, interactions with vitamin D exposure, and breast cancer risk among Caucasian women in Ontario. Cancer Epidemiol Biomarkers Prev 2011;20:1708–17
   PubMed Web of Science ®Google Scholar
• Peehl DM, Skowronski RJ, Leung GK, et al. Antiproliferative effects of 1,25-dihydroxyvitamin D3 on primary cultures of human prostatic cells. Cancer Res 1994;54:805–10
   PubMed Web of Science ®Google Scholar
• Oades GM, Dredge K, Kirby RS, Colston KW. Vitamin D receptor-dependent antitumour effects of 1,25-dihydroxyvitamin D3 and two synthetic analogues in three in vivo models of prostate cancer. BJU Int 2002;90:607–16
   PubMed Web of Science ®Google Scholar
• Gregory KJ, Zhao B, Bielenberg DR, et al. Vitamin D binding protein-macrophage activating factor directly inhibits proliferation, migration, and uPAR expression of prostate cancer cells. PLoS One 2010;5:e13428
   PubMed Web of Science ®Google Scholar
• Dimopoulos MA, Germenis A, Savides P, et al. Genetic markers in carcinoma of the prostate. Eur Urol 1984;10:315–16
   PubMed Web of Science ®Google Scholar
• Ahn J, Albanes D, Berndt SI, et al. Vitamin D-related genes, serum vitamin D concentrations and prostate cancer risk. Carcinogenesis 2009;30:769–76
   PubMed Web of Science ®Google Scholar
• Corder EH, Friedman GD, Vogelman JH, Orentreich N. Seasonal variation in vitamin D, vitamin D-binding protein, and dehydroepiandrosterone: risk of prostate cancer in black and white men. Cancer Epidemiol Biomarkers Prev 1995;4:655–9
   PubMed Web of Science ®Google Scholar
• Poynter JN, Jacobs ET, Figueiredo JC, et al. Genetic variation in the vitamin D receptor (VDR) and the vitamin D-binding protein (GC) and risk for colorectal cancer: results from the Colon Cancer Family Registry. Cancer Epidemiol Biomarkers Prev 2010;19:525–36
   PubMed Web of Science ®Google Scholar
• Hibler EA, Hu C, Jurutka PW, et al. Polymorphic variation in the GC and CASR genes and associations with vitamin D metabolite concentration and metachronous colorectal neoplasia. Cancer Epidemiol Biomarkers Prev 2012;21:368–75
   PubMed Web of Science ®Google Scholar
• Zhou L, Zhang X, Chen X, et al. GC Glu416Asp and Thr420Lys polymorphisms contribute to gastrointestinal cancer susceptibility in a Chinese population. Int J Clin Exp Med 2012;5:72–9
   PubMed Web of Science ®Google Scholar
• Flohil SC, De Vries E, Van Meurs JBJ, et al. Vitamin D-binding protein polymorphisms are not associated with development of (multiple) basal cell carcinomas. Exp Dermat 2010;19:1103–5
   PubMed Web of Science ®Google Scholar
• Niino M, Fukazawa T, Kikuchi S, Sasaki H. Therapeutic potential of vitamin D for multiple sclerosis. Curr Med Chem 2008;15:499–505
   PubMed Web of Science ®Google Scholar
• Niino M, Kikuchi S, Fukazawa T, et al. No association of vitamin D-binding protein gene polymorphisms in Japanese patients with MS. J Neuroimmunol 2002;127:177–9
   PubMed Web of Science ®Google Scholar
• Steckley JL, Dyment DA, Sadovnick AD, et al. Genetic analysis of vitamin D related genes in Canadian multiple sclerosis patients. Canadian Collaborative Study Group. Neurology 2000;54:729–32
   PubMed Web of Science ®Google Scholar
• Rithidech KN, Honikel L, Milazzo M, et al. Protein expression profiles in pediatric multiple sclerosis: potential biomarkers. Mult Scler 2009;15:455–64
   PubMed Web of Science ®Google Scholar
• Hollsberg P, Haahr S, Larsen PM, Fey SJ. MS and the group-specific component. Acta Neurol Scand 1988;78:158–60
   PubMed Web of Science ®Google Scholar
• Lindblom B, Wetterling G, Link H. Distribution of group-specific component subtypes in multiple sclerosis. Acta Neurol Scand 1988;78:443–4
   PubMed Web of Science ®Google Scholar
• Simon KC, Munger KL, Xing Y, Ascherio A. Polymorphisms in vitamin D metabolism related genes and risk of multiple sclerosis. Mult Scler 2010;16:133–8
   PubMed Web of Science ®Google Scholar
• Orton SM, Ramagopalan SV, Para AE, et al. Vitamin D metabolic pathway genes and risk of multiple sclerosis in Canadians. J Neurol Sci 2011;305:116–20
   PubMed Web of Science ®Google Scholar
• Bruijn LI, Miller TM, Cleveland DW. Unraveling the mechanisms involved in motor neuron degeneration in ALS. Annu Rev Neurosci 2004;27:723–49
   PubMed Web of Science ®Google Scholar
• Rosen DR. Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis. Nature 1993;364:362
   PubMed Web of Science ®Google Scholar
• Palma AS, De Carvalho M, Grammel N, et al. Proteomic analysis of plasma from Portuguese patients with familial amyotrophic lateral sclerosis. Amyotroph Lateral Scler 2008;9:339–49
   PubMed Web of Science ®Google Scholar
• McGrath J. Hypothesis: is low prenatal vitamin D a risk-modifying factor for schizophrenia? Schizophr Res 1999;40:173–7
   PubMed Web of Science ®Google Scholar
• Lange V. Genetic markers for schizophrenic subgroups. Psychiatr Clin (Basel) 1982;15:133–44
   PubMedGoogle Scholar
• Papiha SS, Roberts DF, McLeish L. Group-specific component (Gc) subtypes and schizophrenia. Clin Genet 1982;22:321–6
   PubMed Web of Science ®Google Scholar
• Saha N, Tsoi WF. Serum protein markers in Chinese schizophrenics–haptoglobin types and transferrin and group-specific component subtypes. Clin Genet 1990;37:54–8
   PubMed Web of Science ®Google Scholar
• Beckman L, Beckman G, Perris C. Gc serum groups and schizophrenia. Clin Genet 1980;17:149–52
   PubMed Web of Science ®Google Scholar
• Rudduck C, Franzen G, Hansson A, Rorsman B. Gc serum groups in schizophrenia. Hum Hered 1985;35:11–4
   PubMed Web of Science ®Google Scholar
• Fananas L, Moral P, Marti Tusquets JL, Bertranpetit J. Genetic markers in schizophrenia: ACP1, ESD, TF and GC polymorphisms. Hum Hered 1990;40:136–40
   PubMed Web of Science ®Google Scholar
• Sato Y, Kikuyama M, Oizumi K. High prevalence of vitamin D deficiency and reduced bone mass in Parkinson's disease. Neurology 1997;49:1273–8
   PubMed Web of Science ®Google Scholar
• Suzuki M, Yoshioka M, Hashimoto M, et al. 25-Hydroxyvitamin D, vitamin D receptor gene polymorphisms, and severity of Parkinson's disease. Mov Disord 2012;27:264–71
   PubMed Web of Science ®Google Scholar
• Milman N, Thymann M, Graudal N, Morling N. Plasma vitamin D-binding protein (GC) factors, immunoglobulin G heavy chain (GM) allotypes and immunoglobulin kappa light chain (KM1) allotype in patients with sarcoidosis and in healthy control subjects. Sarcoidosis Vasc Diffuse Lung Dis 2002;19:97–100
   PubMed Web of Science ®Google Scholar
• Tokuda N, Mano T, Levy RB. 1,25-Dihydroxyvitamin D3 antagonizes interferon-gamma-induced expression of class II major histocompatibility antigens on thyroid follicular and testicular Leydig cells. Endocrinology 1990;127:1419–27
   PubMed Web of Science ®Google Scholar
• Thomasset M. [Vitamin D and the immune system]. Pathol Biol (Paris) 1994;42:163–72
   PubMedGoogle Scholar
• Pani MA, Regulla K, Segni M, et al. A polymorphism within the vitamin D-binding protein gene is associated with Graves' disease but not with Hashimoto's thyroiditis. J Clin Endocrinol Metab 2002;87:2564–7
   PubMed Web of Science ®Google Scholar
• Kurylowicz A, Ramos-Lopez E, Bednarczuk T, Badenhoop K. Vitamin D-binding protein (DBP) gene polymorphism is associated with Graves' disease and the vitamin D status in a Polish population study. Exp Clin Endocrinol Diabetes 2006;114:329–35
   PubMed Web of Science ®Google Scholar
• Jasmer RM, Nahid P, Hopewell PC. Clinical practice. Latent tuberculosis infection. N Engl J Med 2002;347:1860–6
   PubMed Web of Science ®Google Scholar
• Davies PD. A possible link between vitamin D deficiency and impaired host defence to Mycobacterium tuberculosis. Tubercle 1985;66:301–6
   PubMedGoogle Scholar
• Davies PD, Brown RC, Woodhead JS. Serum concentrations of vitamin D metabolites in untreated tuberculosis. Thorax 1985;40:187–90
   PubMed Web of Science ®Google Scholar
• Grange JM, Davies PD, Brown RC, et al. A study of vitamin D levels in Indonesian patients with untreated pulmonary tuberculosis. Tubercle 1985;66:187–91
   PubMedGoogle Scholar
• Chan TY, Poon P, Pang J, et al. A study of calcium and vitamin D metabolism in Chinese patients with pulmonary tuberculosis. J Trop Med Hyg 1994;97:26–30
   PubMed Web of Science ®Google Scholar
• Sasidharan PK, Rajeev E, Vijayakumari V. Tuberculosis and vitamin D deficiency. J Assoc Physicians India 2002;50:554–8
   PubMedGoogle Scholar
• Sita-Lumsden A, Lapthorn G, Swaminathan R, Milburn HJ. Reactivation of tuberculosis and vitamin D deficiency: the contribution of diet and exposure to sunlight. Thorax 2007;62:1003–7
   PubMed Web of Science ®Google Scholar
• Gibney KB, MacGregor L, Leder K, et al. Vitamin D deficiency is associated with tuberculosis and latent tuberculosis infection in immigrants from sub-Saharan Africa. Clin Infect Dis 2008;46:443–6
   PubMed Web of Science ®Google Scholar
• Martineau AR, Wilkinson RJ, Wilkinson KA, et al. A single dose of vitamin D enhances immunity to mycobacteria. Am J Respir Crit Care Med 2007;176:208–13
   PubMed Web of Science ®Google Scholar
• Martineau AR, Leandro AC, Anderson ST, et al. Association between Gc genotype and susceptibility to TB is dependent on vitamin D status. Eur Respir J 2010;35:1106–12
   PubMed Web of Science ®Google Scholar
• Petrini M, Emerson DL, Galbraith RM. Linkage between surface immunoglobulin and cytoskeleton of B lymphocytes may involve Gc protein. Nature 1983;306:73–4
   PubMed Web of Science ®Google Scholar
• Bahr GM, Eales LJ, Nye KE, et al. An association between Gc (vitamin D-binding protein) alleles and susceptibility to rheumatic fever. Immunology 1989;67:126–8
   PubMed Web of Science ®Google Scholar
• Carter CA, Ehrlich LS. Cell biology of HIV-1 infection of macrophages. Annu Rev Microbiol 2008;62:425–43
   PubMed Web of Science ®Google Scholar
• Kuroda MJ. Macrophages: do they impact AIDS progression more than CD4 T cells? J Leukoc Biol 2010;87:569–73
   PubMed Web of Science ®Google Scholar
• Yamamoto N, Ushijima N, Koga Y. Immunotherapy of HIV-infected patients with Gc protein-derived macrophage activating factor (GcMAF). J Med Virol 2009;81:16–26
   PubMed Web of Science ®Google Scholar
• Pronk JC, Frants RR, Crusius B, et al. No predictive value of GC phenotypes for HIV infection and progression to AIDS. Hum Genet 1988;80:181–2
   PubMed Web of Science ®Google Scholar
• Goudsmit J, de WF, Paul DA, et al. Expression of human immunodeficiency virus antigen (HIV-Ag) in serum and cerebrospinal fluid during acute and chronic infection. Lancet 1986;2:177–80
   PubMed Web of Science ®Google Scholar
• Lange JM, Paul DA, Huisman HG, et al. Persistent HIV antigenaemia and decline of HIV core antibodies associated with transition to AIDS. Br Med J (Clin Res Ed) 1986;293:1459–62
   PubMed Web of Science ®Google Scholar
• de WF, Goudsmit J, Paul DA, et al. Risk of AIDS related complex and AIDS in homosexual men with persistent HIV antigenaemia. Br Med J (Clin Res Ed) 1987;295:569–72
   PubMed Web of Science ®Google Scholar
• Alonso A, Montesino M, Iturralde MJ, et al. GC subtyping and HIV infection in a Spanish population: no evidence of an association between GC subtypes and AIDS. Hum Hered 1990;40:34–7
   PubMed Web of Science ®Google Scholar
• Cleve H, Weidinger S, Gurtler LG, Deinhardt F. AIDS: no association with the genetic systems GC (D-binding protein), ORM (orosomucoid = alpha-1-acid glycoprotein), and A2HS (alpha-2-HS-glycoprotein). Infection 1988;16:31–5
   PubMed Web of Science ®Google Scholar
• Putkonen P, Albert J, Karlsson A, et al. Group specific component and susceptibility to HIV infection and progression to AIDS. Scand J Infect Dis 1988;20:11–4
   PubMed Web of Science ®Google Scholar
• Eales LJ, Nye KE, Parkin JM, et al. Association of different allelic forms of group specific component with susceptibility to and clinical manifestation of human immunodeficiency virus infection. Lancet 1987;1:999–1002
   PubMed Web of Science ®Google Scholar
• Nagasawa H, Sasaki H, Uto Y, et al. Association of the macrophage activating factor (MAF) precursor activity with polymorphism in vitamin D-binding protein. Anticancer Res 2004;24:3361–66
   PubMed Web of Science ®Google Scholar
• Adorini L, Penna G. Control of autoimmune diseases by the vitamin D endocrine system. Nat Clin Pract Rheumatol 2008;4:404–12
   PubMedGoogle Scholar
• Dong X, Lutz W, Schroeder TM, et al. Regulation of relB in dendritic cells by means of modulated association of vitamin D receptor and histone deacetylase 3 with the promoter. Proc Natl Acad Sci USA 2005;102:16007–12
   PubMed Web of Science ®Google Scholar
• Bondy B. Genetics in psychiatry: are the promises met? World J Biol Psychiatry 2011;12:81–8
   PubMed Web of Science ®Google Scholar
• Cooper JD, Smyth DJ, Walker NM, et al. Inherited variation in vitamin d genes is associated with predisposition to autoimmune disease type 1 diabetes. Diabetes 2011;60:1624–31
   PubMed Web of Science ®Google Scholar
• Hodge SE, Anderson CE, Neiswanger K, et al. Association studies between Type 1 (insulin-dependent) diabetes and 27 genetic markers: lack of association between Type 1 diabetes and Kidd blood group. Diabetologia 1983;25:343–7
   PubMed Web of Science ®Google Scholar
• Eichner JE, Cauley JA, Ferrell RE, et al. Genetic variation in two bone-related proteins: is there an association with bone mineral density or skeletal size in postmenopausal women? Genet Epidemiol 1992;9:177–84
   PubMed Web of Science ®Google Scholar
• Rosberger DF, Werner PA, Steinman R, et al. Group specific component (Gc) and HIV diseases. Dis Markers 1988;6:269–74
   PubMed Web of Science ®Google Scholar